Seqens Seqens

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Digital content for Exela Pharma Sciences, LLC.

    Client Virtual Booth

    EXELA PHARMA SCIENCES, LLC.

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Formulations

    INSPECTIONS & REGISTRATIONS

    PharmaCompass
    Contact SupplierContact Supplier
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Send me more info on How To Grow My Bussiness Digitally?
    Exela Pharma Sciences, LLC.
    United_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    Exela Pharma Sciences, LLC 1245 Blowing Rock Blvd Lenoir, NC 28645 USA
    Telephone
    Telephone
    828.758.5474
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    http://www.exela.us/
    Linkedin
    Linkedin
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Full View ScreenFull Screen View
    Enforcement Report - Week of November 29, 2023
    Enforcement Report - Week of November 29, 2023

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-november-29-2023-18805.pdf

    FDA
    29 Nov 2023
    Share Share
    Exela Pharma's Generic Acetylcysteine Receives Approval in the U.S.
    Exela Pharma's Generic Acetylcysteine Receives Approval in the U.S.

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205643

    FDA
    01 Nov 2023
    Share Share
    Exela recalls 3 separate drugs over particulate concerns
    Exela recalls 3 separate drugs over particulate concerns

    https://www.fiercepharma.com/pharma/specialty-injectables-maker-exela-issues-recall-after-particles-turn-3-different-drugs

    Fraiser Kansteiner FIERCE PHARMA
    27 Oct 2023
    Share Share
    Exela Pharma Sciences, LLC Issues Voluntary Nationwide Recall of 8.4% Sodium Bicarbonate Injection, USP, 50 mEq/50 mL, Midazolam in 0.8% Sodium Chloride Injection 100 mg/100 mL, and ELCYS (cysteine hydrochloride Injection), USP 500 mg/10 mL Due to the Presence of Particulate Matter
    Exela Pharma Sciences, LLC Issues Voluntary Nationwide Recall of 8.4% Sodium Bicarbonate Injection, USP, 50 mEq/50 mL, Midazolam in 0.8% Sodium Chloride Injection 100 mg/100 mL, and ELCYS (cysteine hydrochloride Injection), USP 500 mg/10 mL Due to the Presence of Particulate Matter

    https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/exela-pharma-sciences-llc-issues-voluntary-nationwide-recall-84-sodium-bicarbonate-injection-usp-50

    FDA
    25 Oct 2023
    Share Share
    Enforcement Report - Week of December 21, 2022
    Enforcement Report - Week of December 21, 2022

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-december-21-2022-3491.pdf

    FDA
    21 Dec 2022
    Share Share
    Exela Pharma Sciences, LLC Expands Voluntary Nationwide Recall of Sodium Bicarbonate Injection
    Exela Pharma Sciences, LLC Expands Voluntary Nationwide Recall of Sodium Bicarbonate Injection

    https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/exela-pharma-sciences-llc-expands-voluntary-nationwide-recall-sodium-bicarbonate-injection-usp-84-50

    FDA
    29 Nov 2022
    Share Share
    Enforcement Report - Week of November 2, 2022
    Enforcement Report - Week of November 2, 2022

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-november-2-2022-77418.pdf

    FDA
    02 Nov 2022
    Share Share
    Exela's Generic Cupric Chloride Receives Approval in the U.S.
    Exela's Generic Cupric Chloride Receives Approval in the U.S.

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212071

    FDA
    31 Oct 2022
    Share Share
    Flying glass fears force Exela to recall 49 lots of metabolic acidosis injection
    Flying glass fears force Exela to recall 49 lots of metabolic acidosis injection

    https://www.fiercepharma.com/manufacturing/contents-under-pressure-exela-recalls-49-lots-metabolic-acidosis-injection-over-fear

    Catherine Eckford FIERCEPHARMA
    14 Oct 2022
    Share Share
    Exela Pharma Sciences, LLC Issues Voluntary Nationwide Recall of Sodium Bicarbonate Injection
    Exela Pharma Sciences, LLC Issues Voluntary Nationwide Recall of Sodium Bicarbonate Injection

    https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/exela-pharma-sciences-llc-issues-voluntary-nationwide-recall-sodium-bicarbonate-injection-usp-84-50

    FDA
    13 Oct 2022
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    veranova-m-2024-04-22

    Access Virtual Booth

    Contact Supplier

    Send me more info on How To Grow My Business Digitally?
    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search